We Need To Talk About Ozempic
Summary
Dr. K examines the psychiatric effects of GLP-1 agonists like Ozempic, explaining how they blunt dopamine spikes to reduce addictions such as alcohol and binge eating. However, this mechanism can cause anhedonia, depression, and increased suicidality, particularly in individuals at a healthy weight. The episode warns that while these drugs help obese patients by alleviating inflammation-related mood issues, they may trigger or worsen restrictive eating disorders like anorexia in others. Listeners are urged to weigh individual risk factors and consult doctors before use.
Topics discussed
Sponsors: ChatGPT Work and Toyota National Sales Event
Introduction to GLP-1s and how hormones have differential effects
GLP-1 as a satiety hormone and its role in reducing cravings
Impact of GLP-1s on addictions and capping dopamine spikes
Specific effects on alcohol consumption and other substances
The 'Ozempic Personality': Depression, anhedonia, and mood risks
Risk-benefit analysis: Obesity vs. healthy weight users
GLP-1s and eating disorders: Binge eating vs. Anorexia
Triggers for atypical anorexia and the 'Ozempic Face'
Conclusion: Individualized decisions and mental health warnings
Outro sponsors: ChatGPT Work and SimpliSafe
Listen ad-free on Castria